Publications by authors named "Flora Ferrari"

Claim this Profile
I
Improved efficacy, tolerance, safety, and abuse liability profile of the combination of CR4056 and morphine over morphine alone in rodent models.
Emanuele Sala, Flora Ferrari, Marco Lanza, Chiara Milia, Chiara Sabatini

Br J Pharmacol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological characterisation of CR6086, a potent prostaglandin E receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drug.
Gianfranco Caselli, Albino Bonazzi, Marco Lanza, Flora Ferrari, Daniele Maggioni

Arthritis Res Ther· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of CR4056, a first-in-class imidazoline-2 analgesic drug, in comparison with naproxen in two rat models of osteoarthritis.
Eleonora Comi, Marco Lanza, Flora Ferrari, Valeria Mauri, Gianfranco Caselli

J Pain Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological profile and bioavailability of imidazoline compounds on morphine tolerance modulation.
Giovanni Caprioli, Valerio Mammoli, Massimo Ricciutelli, Gianni Sagratini, Massimo Ubaldi, Flora Ferrari

Eur J Pharmacol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of imidazoline I2 binding sites by CR4056 relieves postoperative hyperalgesia in male and female rats.
Marco Lanza, Flora Ferrari, Ilaria Menghetti, Dario Tremolada, Gianfranco Caselli

Br J Pharmacol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats.
Cristina Meregalli, Cecilia Ceresa, Annalisa Canta, Valentina Alda Carozzi, Alessia Chiorazzi, Flora Ferrari

J Pain Res· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New anthranilic acid based antagonists with high affinity and selectivity for the human cholecystokinin receptor 1 (hCCK1-R).
Michela V Pavan, Lucia Lassiani, Federico Berti, Giorgio Stefancich, Alessia Ciogli, Flora Ferrari

J Med Chem· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic pain.
Flora Ferrari, Simonetta Fiorentino, Laura Mennuni, Paolo Garofalo, Ornella Letari

J Pain Res· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and biological evaluation of AT1 angiotensin II receptor antagonists based on the pyrazolo[3,4-b]pyridine and related heteroaromatic bicyclic systems.
Andrea Cappelli, Chiara Nannicini, Andrea Gallelli, Germano Giuliani, Salvatore Valenti, Flora Ferrari

J Med Chem· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Further studies on imidazo[4,5-b]pyridine AT1 angiotensin II receptor antagonists. Effects of the transformation of the 4-phenylquinoline backbone into 4-phenylisoquinolinone or 1-phenylindene scaffolds.
Andrea Cappelli, Gal la Pericot Mohr, Germano Giuliani, Simone Galeazzi, Maurizio Anzini, Flora Ferrari

J Med Chem· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological profile of CR3465, a new leukotriene CysLT1 receptor antagonist with broad anti-inflammatory activity.
Flora Ferrari, Laura Mennuni, Gianfranco Caselli, Tiziano Zanelli, Francesco Makovec

Eur J Pharmacol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT(1) angiotensin II receptor antagonists based on the 4-phenylquinoline structure.
Andrea Cappelli, Gal la Pericot Mohr Gl, Andrea Gallelli, Milena Rizzo, Maurizio Anzini, Flora Ferrari

J Med Chem· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis